| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
November 3, 2026Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced U.S. FDA clearance of the Access MeMed BV® assay, a rapid host-response blood test that...
October 14, 2026Experienced global healthcare leader to accelerate innovation and expand its impact for laboratories, clinicians and patients. BREA, Calif., Oct. 14, 2026 /PRNewswire/ -- Beckman Coulter...
July 23, 2026The DxU 1800 System features new urine chemistry analyzer and consumables with market-leading microscopy helping laboratories to meet rising diagnostic demand BREA, Calif., July 23, 2026...
July 7, 2026CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe Brain Derived pTau217 RUO...
-
April 13, 2026
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April...
September 10, 2025Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in...
March 10, 2025The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...
January 28, 2025Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's...
January 15, 2025New, Fully Automated, High-Throughput RUO Assays offered on Beckman Coulter Immunoassay Analyzers BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in...
September 17, 2024Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term...
July 30, 2024The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain. These tools have the potential to be used to...
July 25, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its...
-
July 9, 2024
Ideale sia per laboratori spoke che piccoli, il nuovo analizzatore DxC 500i offre flessibilità, scalabilità e standardizzazione dei dati con un ampio menu di dosaggi di chimica clinica e...
-
July 9, 2024
Idéal pour les laboratoires périphériques ou indépendants, le nouvel analyseur DxC 500i offre une flexibilité, une évolutivité et une commutabilité des données grâce à un menu étendu...
-
July 9, 2024
Ideal para laboratorios satélites e independientes, el nuevo analizador DxC 500i ofrece flexibilidad, escalabilidad e intercambiabilidad de datos con un extenso menú de ensayos de química...
-
July 9, 2024
Das neue Analysensystem DxC 500i ist perfekt für Satelliten- und unabhängige Labore geeignet, da es Flexibilität, Skalierbarkeit und Datenaustausch bietet und gleichzeitig über ein umfassendes...
July 9, 2024Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC...
May 29, 2024New Access NT-proBNP Assay Detects Heart Failure Biomarker in Less than 11 Minutes Patient Results Evaluated Within Context of Clinically Relevant Age-Based Cutoffs, Disease Comorbidity Data and...
May 7, 2024Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman...
-
April 16, 2024
Barcelona, 16 de abril de 2024 — A Beckman Coulter Diagnostics, uma das líderes mundiais em diagnósticos clínicos, anunciou hoje, antes do Congresso Europeu de Microbiologia Clínica e...
-
April 16, 2024
Barcellona, 16 aprile 2024. Beckman Coulter Diagnostics, leader nella diagnostica clinica, ha annunciato oggi, in vista del Congresso europeo di microbiologia clinica e malattie infettive...
-
April 16, 2024
Barcelona, 16 de abril de 2024: Beckman Coulter Diagnostics, uno de los líderes en diagnóstico clínico, ha anunciado hoy, con motivo del Congreso Europeo de Microbiología Clínica y...
-
April 16, 2024
Barcelona, 16. April 2024 – Beckman Coulter Diagnostics, ein führendes Unternehmen im Bereich der klinischen Diagnostik, gab heute im Vorfeld des European Society of Clinical Microbiology and...
April 16, 2024Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that...
March 12, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their...
